Stefano Zamuner
Stevenage, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Correction to: Mathematical Modelling of Alternative Pathway of Complement System.
Journal: Bulletin of mathematical biology
Published: December 19, 2021
A common root for coevolution and substitution rate variability in protein sequence evolution.
Journal: Scientific reports
Published: July 30, 2019
Mathematical Modelling of Alternative Pathway of Complement System.
Journal: Bulletin of mathematical biology
Published: June 07, 2019
Toward a unified scoring function for native state discrimination and drug-binding pocket recognition.
Journal: Physical chemistry chemical physics : PCCP
Published: June 15, 2018
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: May 23, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug Toxicology.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: May 23, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patients.
Journal: British journal of clinical pharmacology
Published: April 17, 2018
Analysis of variability in length of sleep state bouts reveals memory-free sleep subcomponents consistent among primary insomnia patients.
Journal: Journal of neurophysiology
Published: February 01, 2018
In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
Journal: British journal of clinical pharmacology
Published: October 09, 2017
CCL20 neutralization by a monoclonal antibody in healthy subjects selectively inhibits recruitment of CCR6+ cells in an experimental suction blister.
Journal: British journal of clinical pharmacology
Published: August 11, 2016
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.
Journal: Lupus
Published: April 09, 2016
Last Updated: 09/26/2026